Descubra el nuevo Chem-Impex: donde la innovación comienza con un vínculo.

Catalog Number:
37802
CAS Number:
114977-28-5
Docetaxel
Purity:
97,8 - 102,0 % (ensayo en base anhidra y libre de solventes)
Synonym(s):
N -debenzoil- N -terc-butoxicarbonil-10-desacetiltaxol
Documents
$35.00 /100 mg
Tamaño
Request Bulk Quote
Información del producto

Docetaxel is a potent chemotherapeutic agent widely recognized for its effectiveness in treating various cancers, including breast, lung, and prostate cancer. As a member of the taxane family, it functions by inhibiting cell division, thereby preventing the growth and spread of cancerous cells. This compound is particularly valued in oncology due to its ability to enhance the efficacy of other treatments and its unique mechanism of action, which stabilizes microtubules and disrupts normal mitotic processes.

In clinical settings, Docetaxel is often utilized in combination therapies, maximizing therapeutic outcomes while minimizing resistance. Its formulation as an injectable solution allows for controlled administration, making it a preferred choice among healthcare professionals. Additionally, ongoing research continues to explore its potential in treating other malignancies and its role in personalized medicine, highlighting its versatility and importance in modern cancer treatment protocols.

Número CAS
114977-28-5
Fórmula molecular
C 43 H 53 N.º 14
Peso molecular
807.89
Número MDL
MFCD00800737
Punto de fusión
188 °C (descenso)
Rotación óptica
[a] D 20 = -45 a -35 ° (en el estado actual)
Condiciones
Conservar entre 2 y 8 °C.
Información general
Número CAS
114977-28-5
Fórmula molecular
C 43 H 53 N.º 14
Peso molecular
807.89
Número MDL
MFCD00800737
Punto de fusión
188 °C (descenso)
Rotación óptica
[a] D 20 = -45 a -35 ° (en el estado actual)
Condiciones
Conservar entre 2 y 8 °C.
Propiedades
¡Pronto habrá más información sobre la propiedad!
-
Seguridad y normativas
Materiales peligrosos
-
Antibiótico
-
Regulado por la DEA
No
Advertencias
-
Aplicaciones

Docetaxel is widely utilized in research focused on:

  • Cancer Treatment: Primarily used as a chemotherapy drug for treating various types of cancer, including breast, lung, and prostate cancer. Its effectiveness in disrupting cancer cell division makes it a cornerstone in oncological therapies.
  • Combination Therapies: Often combined with other medications to enhance treatment efficacy. For example, it can be paired with corticosteroids to reduce side effects and improve patient outcomes.
  • Pharmaceutical Research: Used in the development of new formulations and drug delivery systems, allowing researchers to explore innovative ways to improve drug absorption and reduce toxicity.
  • Clinical Trials: Frequently involved in clinical studies aimed at assessing new treatment regimens or combinations, providing valuable data that can lead to improved cancer therapies.
  • Biotechnology Applications: Employed in the production of biosimilars, which are biologic medical products highly similar to already approved reference products, helping to expand treatment options for patients.

Citas